真空辅助乳腺锥形束CT引导活检的可行性及其与俯卧位立体定向活检的比较
这项回顾性临床试验评估了锥形束CT引导乳腺真空辅助活检(VAB)的可行性,并与俯卧位立体定向VAB进行比较。CT引导VAB技术成功率为31/33个病灶(93.9%),俯卧位立体定向VAB为37/38个病灶(97.4%);CT引导VAB平均总介入时间为22.7±8.4分钟,显著快于俯卧位立体定向VAB的28.8±9.4分钟(p<0.05)。两种系统均未观察到重大并发症,CT引导VAB安全可行,且总介入时间和组织取样时间显著更快。
要点
- CT引导VAB技术成功率为93.9%(31/33个病灶),俯卧位立体定向VAB为97.4%(37/38个病灶)。
- CT引导VAB平均总介入时间为22.7±8.4分钟,显著快于俯卧位立体定向VAB的28.8±9.4分钟(p<0.05)。
- 两种系统均未观察到重大并发症。
核心结论
- 使用现有乳腺锥形束CT协议,CT引导VAB安全可行;与俯卧位立体定向VAB相比,CT引导VAB完成VAB的平均总介入时间和组织取样时间显著更快。
研究设计与样本
- 回顾性临床试验,2015年6月至2016年3月共65例患者68个目标病灶接受影像引导VAB;CT引导VAB组29例患者31个病灶,俯卧位立体定向VAB组36例患者37个病灶;采用专用乳腺锥形束CT协议。
诊断标准与关键数值
- CT引导VAB技术成功率为31/33个病灶(93.9%);俯卧位立体定向VAB技术成功率为37/38个病灶(97.4%);两组病灶类型无差异(p=0.135)。
临床应用与阅片要点
- CT引导VAB平均总介入时间为22.7±8.4分钟,俯卧位立体定向VAB为28.8±9.4分钟(p<0.05);两种系统重新识别和定位病灶所用时间大致相同(p=0.362);CT引导VAB组织取样时间显著更快(p<0.05);两种系统均未观察到重大并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The feasibility of breast vacuum-assisted biopsy (VAB) guided by cone-beam CT (CBCT) was assessed. The initial clinical performance of CT-guided breast VAB was compared with that of established prone stereotactic VAB.
MATERIALS AND METHODS: In this retrospective clinical trial, VABs were performed for women with mammographically suspicious breast lesions using a dedicated breast CBCT protocol. The technical success rate, total intervention time, and complications were documented and compared with examinations performed by prone stereotactic VAB.
RESULTS: Between June 2015 and March 2016, 65 patients with 68 target lesions underwent image-guided VAB. CT-guided VAB was performed for 29 patients with 31 lesions. Thirty-six patients with 37 lesions underwent prone stereotactic VAB. The type of lesion was not different between the two groups (p = 0.135). Technical success rate was achieved in 31 of 33 lesions (93.9%) with CT-guided VAB versus 37 of 38 lesions (97.4%) with prone stereotactic VAB. The mean (± SD) total intervention time was 22.7 ± 8.4 minutes for CT-guided VAB versus 28.8 ± 9.4 minutes for prone stereotactic VAB (p < 0.05). Reidentifying and targeting lesions took about the same time for both systems (p = 0.362). The time for tissue sampling was significantly faster with CT-guided VAB (p < 0.05). No major complications were observed with either system.
CONCLUSION: CT-guided VAB is safe and feasible using the currently available breast CBCT protocol. The mean total intervention time to complete VAB and the time for tissue sampling was significantly faster using CT-guided VAB in comparison with prone stereotactic VAB.
引用
- Wienbeck S, Lotz J, Fischer U, et al. Feasibility of Vacuum-Assisted Breast Cone-Beam CT-Guided Biopsy and Comparison With Prone Stereotactic Biopsy. AJR Am J Roentgenol. 2017. PMID: 28199139. doi:10.2214/AJR.16.16760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。